- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
76 Depression Trials near Atlanta, GA
Power is an online platform that helps thousands of Depression patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerSEP-363856 for Major Depressive Disorder
Trial Details
Key Eligibility Criteria
900 Participants Needed
Osavampator as an Adjunctive Treatment for Depression
Trial Details
Key Eligibility Criteria
200 Participants Needed
CYB003 for Depression
Trial Details
Key Eligibility Criteria
330 Participants Needed
ABX-002-2001 for Depression
Trial Details
Key Eligibility Criteria
230 Participants Needed
Psychedelic-Assisted Therapy for Treatment Resistant Depression
Trial Details
Key Eligibility Criteria
142 Participants Needed
Mindfulness Approaches for Living After Breast Cancer
Trial Details
Key Eligibility Criteria
402 Participants Needed
Psilocybin Analog for Depression
Trial Details
Key Eligibility Criteria
220 Participants Needed
Azetukalner for Depression
Trial Details
Key Eligibility Criteria
450 Participants Needed
Azetukalner for Depression
Trial Details
Key Eligibility Criteria
460 Participants Needed
Azetukalner for Depression
Trial Details
Key Eligibility Criteria
450 Participants Needed
Esketamine vs. Ketamine for Depression
Trial Details
Key Eligibility Criteria
400 Participants Needed
CYB003 for Depression
Trial Details
Key Eligibility Criteria
468 Participants Needed
NMRA-335140 for Depression
Trial Details
Key Eligibility Criteria
332 Participants Needed
NMRA-335140 for Depression
Trial Details
Key Eligibility Criteria
332 Participants Needed
NMRA-335140 for Depression
Trial Details
Key Eligibility Criteria
1000 Participants Needed
Lumateperone for Major Depressive Disorder
Trial Details
Key Eligibility Criteria
470 Participants Needed
Cariprazine for Bipolar Disorder in Youth
Trial Details
Key Eligibility Criteria
380 Participants Needed
Dopaminergic Therapy for Depression with Anhedonia
Trial Details
Key Eligibility Criteria
70 Participants Needed
Leucine for Depression
Trial Details
Key Eligibility Criteria
75 Participants Needed
BI 1569912 for Depression
Trial Details
Key Eligibility Criteria
224 Participants Needed
Why Other Patients Applied
"I have struggled with depression since I was a child. I have experienced about more than 6 major depressive episodes lasting at least 4 months since I was 7 years old. I have tried talk therapy, a plethora of medication, and nothing has worked long term. Medication and talk therapy helps me manage and reduce the length of depressive episodes but I am in search for alternative treatments. My depression has made completing a bachelors degree a major challenge."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"I've been through a substance abuse program three times. Clearly, it's not working. I need to try something totally different and new to deal with my depression (plus alcohol usage) once and for all. I did some research on psilocybin and want to try."
"My long history of depression has been met with a long list of trial and error drugs. My current medication (generic Pristiq) has been prescribed for two decades (though I tried several other medications during my last serious episode several years ago. When the episode passed I returned to generic Pristiq. I am interested in a clinical trial because I wonder if I can do something different to more effectively avoid a serious depressive episode and lift the general malaise I often feel."
"Dealt with treatment-resistant depression for pretty much my entire life. I would be eternally grateful for something that actually worked for once. I'd just like to feel normal. "
Baricitinib for Depression in People With HIV
Trial Details
Key Eligibility Criteria
60 Participants Needed
SPT-300 for Depression
Trial Details
Key Eligibility Criteria
360 Participants Needed
SPT-300 for Depression
Trial Details
Key Eligibility Criteria
360 Participants Needed
Baricitinib for Major Depressive Disorder
Trial Details
Key Eligibility Criteria
100 Participants Needed
Ropanicant for Depression
Trial Details
Key Eligibility Criteria
195 Participants Needed
JNJ-89495120 for Depression
Trial Details
Key Eligibility Criteria
124 Participants Needed
BHV-7000 for Depression
Trial Details
Key Eligibility Criteria
480 Participants Needed
ALTO-203 for Depression
Trial Details
Key Eligibility Criteria
60 Participants Needed
NBI-1070770 for Depression
Trial Details
Key Eligibility Criteria
73 Participants Needed
Zelquistinel for Depression
Trial Details
Key Eligibility Criteria
164 Participants Needed
Know someone looking for new options?
Spread the word
